AdaptHealth Corp. $AHCO Shares Bought by Empirical Financial Services LLC d.b.a. Empirical Wealth Management

Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 21.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 19,307 shares of the company’s stock after purchasing an additional 3,436 shares during the quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in AdaptHealth were worth $182,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. GAMMA Investing LLC raised its holdings in shares of AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock valued at $81,000 after acquiring an additional 4,758 shares during the last quarter. Brooklyn Investment Group raised its holdings in shares of AdaptHealth by 531.8% during the first quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock valued at $82,000 after acquiring an additional 6,366 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of AdaptHealth during the first quarter valued at approximately $114,000. Vident Advisory LLC acquired a new position in shares of AdaptHealth during the first quarter valued at approximately $163,000. Finally, Legato Capital Management LLC acquired a new position in shares of AdaptHealth during the first quarter valued at approximately $167,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Wall Street Zen raised AdaptHealth from a “buy” rating to a “strong-buy” rating in a report on Friday, October 3rd. Weiss Ratings reissued a “sell (d+)” rating on shares of AdaptHealth in a report on Saturday, September 27th. Finally, Zacks Research cut AdaptHealth from a “hold” rating to a “strong sell” rating in a report on Friday, September 19th. Five investment analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $13.40.

Insider Activity

In related news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $9.73, for a total value of $79,786.00. Following the completion of the transaction, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. This represents a 14.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 1.55% of the stock is owned by company insiders.

AdaptHealth Price Performance

AHCO stock opened at $9.02 on Wednesday. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 0.82. The business has a 50 day simple moving average of $9.23 and a 200-day simple moving average of $9.10. The firm has a market capitalization of $1.22 billion, a PE ratio of 16.70, a price-to-earnings-growth ratio of 1.00 and a beta of 1.61. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.63.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.